News
Oculogica in the news
Rosina Samadani and Dr. Uzma Samadani discuss EyeBOX on Talk Polymath podcast
Watch Oculogica CEO, Dr. Rosina Samadani's, and founder, Dr. Uzma Samadani's discussion with the Talk Polymath podcast about the EyeBOX and how eye movement can ...
CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica
Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.
Oculogica new patient opens potential CTE test for live subjects
Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology
Oculogica adds patent for assessment of Impairment due to Cannabis
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica receives DoD Grant for Development of Wearable concussion diagnostic
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable ...
Australia Grant Approves First Objective Concussion Diagnostic tool
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its ...
Oculogica Adds to IP Portfolio with Patent for Glaucoma
Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This ...
Dr. Uzma Samadani and Rosina Samadani Named to list of Most Creative People in Business
Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, ...
Fast Company: Samadani sisters invent better way to diagnosis concussion with eye tracking
Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed ...